Related Experiment Video

Updated: May 12, 2026

Using the E1A Minigene Tool to Study mRNA Splicing Changes
10:25

Using the E1A Minigene Tool to Study mRNA Splicing Changes

Published on: April 22, 2021

In non-small cell lung cancer mitogenic signaling leaves Sprouty1 protein levels unaffected

Rosana Maria Kral1, Christoph-Erik Mayer, Vanita Vanas

  • 1Institute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.

Cell Biochemistry and Function
|April 26, 2013
PubMed

Insights

Sprouty1 protein levels remain constant in non-small cell lung carcinoma cells, regardless of serum content or cell cycle stage. This suggests Sprouty1 expression is independent of mitogenic signaling and cell proliferation.

Area of Science:

  • Molecular Biology
  • Cell Signaling

Background:

  • Sprouty1 protein is an inhibitor in receptor tyrosine kinase signaling pathways.
  • Its expression is typically regulated by growth factors in a negative feedback loop.
  • Previous studies observed fluctuations in Sprouty1 mRNA levels.

Purpose of the Study:

  • To investigate Sprouty1 protein levels in non-small cell lung carcinoma (NSCLC) cells.
  • To determine the relationship between Sprouty1 expression, mitogenic signaling, and cell proliferation.

Main Methods:

  • Analysis of Sprouty1 protein levels in NSCLC-derived cells.
  • Investigation of effects of serum content, serum starvation, and growth factors on Sprouty1 expression.
  • Cell cycle analysis to assess Sprouty1 levels throughout cell division.
  • Examination of Sprouty1 expression in cells with K-Ras mutations and ectopic Ras expression.

Main Results:

  • Sprouty1 protein levels in NSCLC cells were unaffected by serum content.
  • Serum starvation for three days did not alter Sprouty1 expression.
  • Addition of serum or individual growth factors did not change Sprouty1 protein levels.
  • Cells with K-Ras mutations showed only slightly higher Sprouty1 levels, and ectopic Ras expression did not increase Sprouty1.
  • Sprouty1 levels remained constant throughout all phases of the cell cycle.

Conclusions:

  • Sprouty1 protein expression is not linked to mitogenic signaling pathways.
  • Sprouty1 levels are independent of cell proliferation.
  • The regulation of Sprouty1 protein differs from its mRNA regulation in response to growth factors.
Keywords:
NSCLCSproutySpry1cell cycle

More Related Videos

The use of SC1 (Pluripotin) to Support mESC Self-renewal in the Absence of LIF05:58

The use of SC1 (Pluripotin) to Support mESC Self-renewal in the Absence of LIF

Published on: November 18, 2009

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...